Exchange: NYSEArca·Updated 07:30 PM EDT

KOMP News

News
all
press releases
LI Stock Jumps as Li Auto Makes Its Second Launch This Month To Chase 20% Delivery Growth
Li Auto called the i9 “a pioneering flagship family SUV.” The six-seat battery-electric vehicle is priced at RMB 369,800 for its standard configuration.
Stocktwits
More News
LI Stock Continues To Hover Near 52-Week Low Despite New, Cheaper MPV Launch
The stock is currently trading around $11.88, just above its 52-week low of $11.65.
Stocktwits
SERV Stock Rallies On Grubhub Partnership, DoorDash Deal Expansion — CEO Calls It 'Clearest Signal Yet Of Where We're Headed'
This comes as Serve Robotics looks to put more robots to work following its recent split with Uber Eats, with the company also launching a new micro-depot model and expanding beyond sidewalk delivery.
Stocktwits
UMAC Stock Might See A 110% Rise From Current Levels, Says Analyst – What’s Driving The Bull Case?
According to TheFly, HC Wainwright initiated coverage of Unusual Machines with a ‘Buy’ rating and a price target of $42.
Stocktwits
Nio Follows Tesla Playbook — Launches New Seating Configuration For Best-Selling SUV
Nio launched a five-seat version of its ES8 SUV on Thursday.
Stocktwits
FCEL Stock Headed For Best Single-Day Gains In Over A Year — Why UBS Tripled Its Price Target For FuelCell
UBS analyst Manav Gupta cited FuelCell’s recently announced strategic partnership with Fit Energy USA as the basis for the bullish outlook on the company.
Stocktwits
XPEV Pops, LI Drops After Earnings: XPeng’s Cost Cuts Outshine Li Auto Discounts
Both XPeng and Li Auto reported a double-digit year-on-year decline in revenue, while still exceeding Wall Street expectations.
Stocktwits
NRGV Stock Clocks Best Week In 8 Months: Retail Cheers 'Fruitful' Long-Term Investment
Energy Vault Holdings has surged nearly 31% last week, driven by investor optimism over its new projects and a strong future outlook.
Stocktwits
OCGN Stock Tanks After Gene Therapy Trial Update — What Did Ocugen Announce?
Ocugen said 12-month Phase 2 trial data showed its drug OCU410 significantly reduced lesion growth at the dose planned for Phase 3.
Stocktwits
Why Is UMAC Stock Falling Today?
Unusual Machines stated that it will issue 8.8 million shares at $17 apiece, a discount of more than 9% to the stock’s closing price on Thursday.
Stocktwits

Advertisement|Remove ads.